IRVA | International Retrovirology Association

What is IRVA?

The International Retrovirology Association (IRVA), through its many varied approaches, aims to encourage research in HTLV infections and diseases.
Learn More

HTLV22 Call to Action

We call on all organisations and individuals to sign on to this call to action posted on the HTLV2022 conference and IRVA website to affirm a commitment to real action, strengthening the global response to HTLV-1.

Sign on to this call

What is HTLV?

HTLV stands for Human T cell Leukemia Virus. It is a retrovirus that infects a type of white blood cell called a T-cell or T-lymphocyte.
Learn More

WHO HTLV Technical Report

Launch of the WHO Technical Report.
Learn More

-SOCIAL MEDIA-

More About HTLV

Read more about HTLV on our social media accounts and Patient Advocacy websites.

WorldHTLV Day

IRVA facebook page (multilingual)

HTLV Twitter

Official IRVA Twitter account

UK HTLV Centre

HTLV Centre (in English)

Talk About HTLV

Raising awareness (in English)

HTLV Aware

HTLV information (in English)

Smile Ribbon

Patient Association (in Japanese)

HTLV Channel

Youtube channel (mostly Portuguese)

HTLV consciente

Official patient website (in Spanish)

HTLV-1関連情報

The Japanese Society of HTLV-1 and Associated Diseases (JSHAD)

HoT LiVes

HTLV-1 Information Portal (in Japanese)

HTLV.ir

HTLV-1 information (in Farsi)

Tweets by @HTLVnet

OUR LATEST PUBLICATIONS

HTLV Publications

View All

Replication Stress Tolerance in Adult T-Cell Leukemia

Replication Stress Tolerance in Adult T-Cell Leukemia

26 Sep | Publications

Biomolecules. 2026 Sep 9;16(9):1310. doi: 10.3390/biom16091310. ABSTRACT Replication stress (RS) represents a major...

The Prevalence of Syphilis, HTLV I/II, and Malaria Among Blood Donors at the Riyadh Regional Laboratory: A Retrospective Study from Saudi Arabia

The Prevalence of Syphilis, HTLV I/II, and Malaria Among Blood Donors at the Riyadh Regional Laboratory: A Retrospective Study from Saudi Arabia

26 Sep | Publications

J Clin Med. 2026 Sep 11;15(18):7058. doi: 10.3390/jcm15187058. ABSTRACT Background: Transfusion-transmitted infections (TTIs)...

$Durable immunovirological control after sequential mogamulizumab and tucidinostat in relapsed or refractory adult T-cell leukemia/lymphoma$

Durable immunovirological control after sequential mogamulizumab and tucidinostat in relapsed or refractory adult T-cell leukemia/lymphoma

23 Sep | Publications

Front Immunol. 2026 Sep 8;17:1919613. doi: 10.3389/fimmu.2026.1919613. eCollection 2026. ABSTRACT Adult T-cell leukemia/lymphoma...

Our Guidelines

Guidelines and Clinical Trials

View All

Ongoing Trial: Human Immune Response

Ongoing Trial: Human Immune Response

by HTLV | 3 May | Clinical Trials

Ongoing clinical trials at NCI that are exclusive to or include patients with ATL: Investigation of the Human Immune Response in...

Ongoing Trial: Subcutaneous Recombinant rhIL-15 & Alemtuzumab

Ongoing Trial: Subcutaneous Recombinant rhIL-15 & Alemtuzumab

by HTLV | 3 May | Clinical Trials

Ongoing clinical trials at NCI that are exclusive to or include patients with ATL: Subcutaneous Recombinant Human IL-15 (s.c....

Planned Trial: rhIL-15 & Mogamulizumab

Planned Trial: rhIL-15 & Mogamulizumab

by HTLV | 3 May | Clinical Trials

Planned trial: Recombinant Human IL-15 (rhIL-15) and Mogamulizumab for Patients with Refractory or Relapsed Adult T-Cell...

EVENTS AND EDUCATION

Scientific Meetings and Public Events

Meetings and events on the impression of people living with HTLV in different countries.

There are no upcoming events at this time.

LATEST NEWS

News

View All

An overview of #WorldHTLVDay2019

An overview of #WorldHTLVDay2019

by HTLV | May 3, 2022 | News

In summary, #HTLV and #WorldHTLVDay have gained momentum in the mainstream press and on social...